Ford P M
Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Curr Opin Rheumatol. 1992 Feb;4(1):63-7.
In recent years most of the interest in musculoskeletal problems secondary to renal disease has focused on problems occurring in patients with chronic renal failure and specifically in patients on long-term hemodialysis. The musculoskeletal involvement in long-term hemodialysis may involve the joints, soft tissues, or both, and there is presently no good classification to which authors may refer when they report musculoskeletal problems in these patients. There has been intense interest in the past few years in the amyloidosis associated with long-term hemodialysis, and now, apparently, also with peritoneal dialysis. This type of amyloidosis is due to a specific type of amyloid, namely beta 2-microglobulin amyloid. Debate is ongoing about the role of both aluminum toxicity and iron deposition as cofactors affecting the location and extent of amyloid deposits. Debate is also unresolved about the role of specific dialysis membranes in lessening the incidence of dialysis-related amyloid. I review some of these areas as well as interesting new developments in localization of amyloid deposits in patients with chronic renal failure who are on hemodialysis.
近年来,对继发于肾脏疾病的肌肉骨骼问题的关注大多集中在慢性肾衰竭患者,特别是长期接受血液透析的患者所出现的问题上。长期血液透析中的肌肉骨骼受累可能涉及关节、软组织或两者皆有,目前尚无一个很好的分类可供作者在报告这些患者的肌肉骨骼问题时参考。在过去几年中,人们对与长期血液透析相关的淀粉样变性病有着浓厚的兴趣,现在显然对腹膜透析相关的淀粉样变性病也有兴趣。这种类型的淀粉样变性病是由一种特定类型的淀粉样蛋白,即β2-微球蛋白淀粉样蛋白引起的。关于铝中毒和铁沉积作为影响淀粉样蛋白沉积位置和范围的辅助因素所起的作用,争论仍在继续。关于特定透析膜在降低透析相关淀粉样变性病发病率方面的作用,争论也尚未解决。我将回顾其中一些领域,以及在接受血液透析的慢性肾衰竭患者中淀粉样蛋白沉积定位方面有趣的新进展。